Clinical trial
Safety and Performance Study of the Harpoon Medical Transapical Suturing Device (TSD-5) in Subjects With Degenerative Mitral Regurgitation - CE Mark Study for the Harpoon Medical Device in Poland
NCT02432196 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Performance Study of the Harpoon Medical Transapical Suturing Device (TSD-5) in Subjects With Degenerative Mitral Regurgitation - CE Mark Study for the Harpoon Medical Device in Poland
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 11, 2015
- Completion date
- November 16, 2022
- Enrollment
- 26 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve insufficiency, mitral valve prolapse, mitral valve regurgitation